Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Fake HIV Medications
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Fake Adderall
    • Social Media & Fake Pills
    • Counterfeit Pill Crisis
  • Patients
    • Learn about Counterfeits and to Save Money Safely
    • The Drug Importation Debate
    • Drug Counterfeiters Get Light Sentences
    • Real Victims of Counterfeit Drugs
    • Talk to Your Family
    • HIV/HEPC Patients
    • Mexican Pharmacies
  • Professionals
    • Pharmacists
    • Doctors
    • Law Enforcement
    • Educators
    • Prosecution Document Library
    • Research On Drug Safety
  • Policy
    • Publications
    • Drug Importation
    • Illegal Pill Presses
    • Affordability Boards (PDABs)
    • FOIA-ed Materials
    • Fake Medicine in Your State
    • Real Victims of Counterfeit Drugs
    • Events, briefings, and op-eds
  • About Us
    • Join Our Mailing List
    • Members
    • PSM Leadership
    • Press Releases
    • Contact Us
Document Tags: Case 9:24-cv-00076-DLC, Complaint, compounding, G2 Telemedicine, GLP-1 lawsuit, Montana, Novo Nordisk, semaglutide
Return to list

United States District Court
District of Montana

Novo Nordisk Inc. v. JAE Medical PLLC dba G2 Telemedicine Weight Loss Clinic

Complaint

May 30, 2024

Read the document.

<a href="https://www.safemedicines.org/wp-content/uploads/2019/09/Novo-Nordisk-v-G2Telemedicine-Complaint.pdf">Novo Nordisk v G2 Telemedicine Weight Loss Clinic </a><br>Filed in Montana, May 30, 2024.
© 2003-2023 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top